drugset / Trial / NCT06232421
Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process
Phase 2/3
Not yet recruiting
224 enrolled
Research Institute for Physical Chemical Problems of the Belarusian State University
The 10th Minsk City Clinical Hospital · collabUnitary Enterprise UNITEHPROM BSU · collabVitebsk Regional Clinical Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to estimate efficiency, tolerance, safety of "Foscelantan, medicinal plate 4.0x5.0 cm in package No. 1" among adult patients who have purulent-inflammatory processes of the skin and soft tissues due to the neuropathic form of diabetic foot syndrome or chronic venous insufficiency, phase I-II of the wound process.
Timeline
- Start
- 2025-11
- Primary completion
- 2026-04
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Foscelantan | Unknown | — | — |
| Comparator | Povidon-iodine | Unknown | 100 mg/ml | — |